Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
BeOne Medicines
Olema Pharmaceuticals, Inc.
Pfizer
Pfizer
Syros Pharmaceuticals
Eli Lilly and Company
University of Wisconsin, Madison